Give us a brief about Ignite Life Science Foundation - the story of its origin, its goal and target audience, etc.
Ignite was launched formally at an event in January 2020 but its story had begun prior to that. It is the brainchild of Professor Ramaswamy Subramanian, who was at that time heading C-CAMP in Bengaluru - a part of the Bangalore biocluster. During his working years in India, he recognised many problems Indian scientists were facing and it was not simply a matter of quantum of funding; there were multiple factors.
Research productivity thrives in a complex ecosystem. Very few countries in the world have succeeded in building such self-sustaining ecosystems consisting of multiple factors -government funding, academic institutions (that are often private) that consider research an important purpose for their existence, ability to attract the best students from the global pool, private philanthropists willing to support science through large endowments and the co-existence of research universities with communities of investors, start-ups and large company R&D facilities The Boston-Cambridge (Harvard) area and the San Francisco Bay Area (Stanford), Cambridge University (Cambridge, UK) and the Stockholm area (Stockholm University) are some examples.
Building out such ecosystems takes time, but Rams and his scientific peers got together with leading business persons and academics in India to find Ignite as an organisation that would nurture good science using philanthropic money. Connecting uHNIs to science in Indian universities is the first step towards getting widespread acknowledgement of the challenges facing Indian science and pooling resources and capabilities to solve some of these challenges - funding is only one among those.
So, Ignite is an organisation with the purpose of building not just good science in the country, but also building research capacity because there are critical areas of research where a capacity in the country is missing because of historical reasons. For example, we don't have good fundamental vaccinology research going on in India as we noticed during this last pandemic. The only vaccine launched used an older technology. There was nobody in India, ready with messenger RNA technology for developing vaccines, and this is important because the fastest route to launch a vaccine is using messenger RNA technology, which is why the Pfizer vaccine got launched way before the Bharat Biotech one.
So, if we see, this is a gap that we identified; but, like this, there are many other missing pieces in the overall puzzle of Indian science. Unless those pieces are filled, Indian science will always find it hard to deliver to the expectations and requirements of India.
There are other healthcare needs in India, which are unique to the country. The second one could be antimicrobial resistance, and the third would be nutrition. So, in some of these areas where India faces unique challenges and problems, Indian capacity needs to be built. Hence, Ignite was found with these two purposes in mind.
Continue reading your story on the app
Continue reading your story in the magazine
Yokogawa launches OpreX Data Model Broker
A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation
Understanding the nuances of generics injectables
At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial
Trending in nutraceuticals: Science meets sustainability
Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe
The growth of e-pharmacies in India
Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these
Xylitol and Maltitol: Low-calorie sugar alternatives
Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste
Single-use TC gaskets and their importance
Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.
It's important to enhance customer experience so that existing customers are more loyal
Sheshgiri Kamath, CEO and co-founder, Kapture CRM, expands on why it is important for pharma companies to enhance customer experience, and how the right CRM solution can help companies to identify, address and manage customer expectations more effectively, in an interaction with Viveka Roychowdhury
From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice
Arun Kedia, Managing Director,VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across various medical therapies ranging from HIV to cancer to COVID-19 treatment
Ensuring pharma compliance with testo data loggers
Testo data loggers can be used to test the optimum conditions for specific products or surroundings
Achieving Aatmanirbharta In APIs Are We On The Right Track?
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats
2022 Cadillac CT5-V Blackwing Bombastic fantastic.
Mirza Grebovic’s eyes light up when he talks about brake pad compounds. He’s Cadillac’s performance variant manager, and his passion clearly goes beyond the paycheck.
THE GIULIA QUADRIFOGLIO AND M3 COMPETITION FACE OFF TO IDENTIFY THE ULTIMATE CHAMP
SEEKING THE COMPACT CROWN
HONDA’S CR-V HAS REIGNED SUPREME. CAN TOYOTA, NISSAN, OR HYUNDAI LEAD AN SUV REVOLUTION?
2022 Mercedes-EQ EQS
Look elsewhere for a Tesla competitor.
2022 Ford Maverick
Small truck, small price, big mpg.
THE REAL DEAL
FORD’S LONG-AWAITED BRONCO IS ABSOLUTELY LEGIT
2022 Porsche 911 GT3
There’s so much more to the new GT3 than its raw speed.
DIDN'T SEE (OR HEAR) IT COMING
THE PLUG-IN FERRARI SF90 STRADALE RADICALLY REDEFINES THE HYPERCAR
The Big Picture
WORLD BEATER: Those still underestimating Hyundai-Kia do so at their own peril.
WELCOME TO THE ROCKET SLED
THE BEST LAID PLANS OF MICEAND 102-YEAR-OLD CARMAKERS